Ignite Creation Date:
2024-05-06 @ 9:40 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03042611
Status:
COMPLETED
Last Update Posted:
2022-07-08
First Post:
2017-01-24
Brief Title:
A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer
Sponsor:
Organization:
Elevar Therapeutics